Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Choristoma | 2 | 2026 | 47 | 1.100 |
Why?
|
| Genitalia, Female | 2 | 2026 | 46 | 1.000 |
Why?
|
| Endometriosis | 2 | 2024 | 176 | 0.810 |
Why?
|
| Uterus | 2 | 2026 | 542 | 0.800 |
Why?
|
| Semen Preservation | 2 | 2020 | 16 | 0.750 |
Why?
|
| Salmo salar | 2 | 2020 | 3 | 0.720 |
Why?
|
| Endometrium | 1 | 2024 | 280 | 0.680 |
Why?
|
| Fallopian Tube Diseases | 1 | 2020 | 6 | 0.650 |
Why?
|
| Genital Diseases, Female | 1 | 2020 | 32 | 0.630 |
Why?
|
| Cryopreservation | 1 | 2020 | 77 | 0.620 |
Why?
|
| Sperm Motility | 1 | 2020 | 113 | 0.610 |
Why?
|
| Uterine Neoplasms | 3 | 2022 | 104 | 0.550 |
Why?
|
| Spermatozoa | 1 | 2020 | 254 | 0.540 |
Why?
|
| Cell Survival | 1 | 2020 | 843 | 0.530 |
Why?
|
| Diethylstilbestrol | 1 | 2014 | 40 | 0.420 |
Why?
|
| Vaginal Neoplasms | 1 | 2014 | 17 | 0.420 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2014 | 39 | 0.410 |
Why?
|
| Fallopian Tubes | 2 | 2024 | 67 | 0.350 |
Why?
|
| Leiomyosarcoma | 1 | 2010 | 23 | 0.310 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 312 | 0.270 |
Why?
|
| Herpesvirus 4, Human | 1 | 2010 | 644 | 0.250 |
Why?
|
| Menstrual Cycle | 1 | 2026 | 33 | 0.240 |
Why?
|
| Ovarian Neoplasms | 2 | 2006 | 452 | 0.230 |
Why?
|
| Lung Transplantation | 1 | 2010 | 353 | 0.220 |
Why?
|
| Chlorella | 1 | 2024 | 3 | 0.210 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2024 | 27 | 0.210 |
Why?
|
| Microalgae | 1 | 2024 | 5 | 0.210 |
Why?
|
| Sewage | 1 | 2024 | 11 | 0.210 |
Why?
|
| Phosphorus | 1 | 2024 | 61 | 0.210 |
Why?
|
| Nitrogen | 1 | 2024 | 120 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 456 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1281 | 0.190 |
Why?
|
| Trophoblastic Neoplasms | 1 | 2022 | 5 | 0.190 |
Why?
|
| Gestational Trophoblastic Disease | 1 | 2022 | 10 | 0.190 |
Why?
|
| Pregnancy, Ectopic | 1 | 2022 | 20 | 0.180 |
Why?
|
| Embryo Implantation | 1 | 2024 | 215 | 0.180 |
Why?
|
| Progesterone | 1 | 2024 | 441 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 772 | 0.160 |
Why?
|
| Ovum | 1 | 2020 | 13 | 0.160 |
Why?
|
| Freezing | 1 | 2020 | 27 | 0.160 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 39 | 0.160 |
Why?
|
| Animals | 6 | 2026 | 34000 | 0.160 |
Why?
|
| Fertilization | 1 | 2020 | 43 | 0.160 |
Why?
|
| Adnexal Diseases | 1 | 2020 | 24 | 0.160 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2020 | 38 | 0.160 |
Why?
|
| Cold Temperature | 1 | 2020 | 81 | 0.160 |
Why?
|
| Genital Neoplasms, Female | 1 | 2020 | 41 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 67 | 0.150 |
Why?
|
| Analgesics | 1 | 2020 | 121 | 0.150 |
Why?
|
| Brachytherapy | 1 | 2020 | 86 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1846 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2020 | 145 | 0.150 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2344 | 0.140 |
Why?
|
| Cell Membrane | 1 | 2020 | 451 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 260 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3839 | 0.120 |
Why?
|
| Insemination, Artificial | 1 | 2015 | 11 | 0.110 |
Why?
|
| Female | 9 | 2024 | 70720 | 0.110 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 2014 | 1 | 0.110 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2014 | 13 | 0.110 |
Why?
|
| Cattle | 1 | 2015 | 501 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 4683 | 0.100 |
Why?
|
| Prevalence | 1 | 2020 | 2692 | 0.100 |
Why?
|
| Hysterectomy | 1 | 2014 | 205 | 0.090 |
Why?
|
| Humans | 9 | 2026 | 130959 | 0.080 |
Why?
|
| Biopsy | 1 | 2014 | 1241 | 0.080 |
Why?
|
| Skin Transplantation | 1 | 2010 | 57 | 0.080 |
Why?
|
| Tissue Scaffolds | 1 | 2010 | 91 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2010 | 362 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6797 | 0.070 |
Why?
|
| Middle Aged | 4 | 2020 | 28553 | 0.070 |
Why?
|
| Photoperiod | 1 | 2008 | 19 | 0.070 |
Why?
|
| Adult | 4 | 2022 | 31296 | 0.070 |
Why?
|
| Digestion | 1 | 2008 | 42 | 0.070 |
Why?
|
| Mice | 1 | 2024 | 18273 | 0.060 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2006 | 8 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2006 | 126 | 0.060 |
Why?
|
| Young Adult | 1 | 2020 | 10016 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2006 | 340 | 0.060 |
Why?
|
| Amino Acids | 1 | 2008 | 566 | 0.060 |
Why?
|
| Aquaculture | 1 | 2024 | 7 | 0.050 |
Why?
|
| Anaerobiosis | 1 | 2024 | 14 | 0.050 |
Why?
|
| Waste Disposal, Fluid | 1 | 2024 | 7 | 0.050 |
Why?
|
| Fishes | 1 | 2024 | 33 | 0.050 |
Why?
|
| Biomass | 1 | 2024 | 25 | 0.050 |
Why?
|
| Fermentation | 1 | 2024 | 67 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 1006 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 1458 | 0.050 |
Why?
|
| Aged | 2 | 2020 | 21005 | 0.050 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2022 | 25 | 0.050 |
Why?
|
| Epithelioid Cells | 1 | 2022 | 12 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 1307 | 0.050 |
Why?
|
| Vaccination | 1 | 2008 | 1039 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17763 | 0.040 |
Why?
|
| Adolescent | 1 | 2020 | 20817 | 0.040 |
Why?
|
| Promethazine | 1 | 2020 | 5 | 0.040 |
Why?
|
| Hydromorphone | 1 | 2020 | 12 | 0.040 |
Why?
|
| Lorazepam | 1 | 2020 | 12 | 0.040 |
Why?
|
| Antiemetics | 1 | 2020 | 21 | 0.040 |
Why?
|
| Organs at Risk | 1 | 2020 | 48 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 41 | 0.040 |
Why?
|
| Rectum | 1 | 2020 | 102 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2020 | 222 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 71 | 0.040 |
Why?
|
| Child | 1 | 2020 | 26220 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1325 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2020 | 220 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1896 | 0.030 |
Why?
|
| Male | 2 | 2020 | 64765 | 0.030 |
Why?
|
| Alginates | 1 | 2015 | 23 | 0.030 |
Why?
|
| Acrosome | 1 | 2015 | 15 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2015 | 43 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2006 | 4672 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1155 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 772 | 0.020 |
Why?
|
| Vulva | 1 | 2010 | 14 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 75 | 0.020 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2010 | 68 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7500 | 0.020 |
Why?
|
| Vagina | 1 | 2010 | 207 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 674 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 2008 | 12 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 463 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 2008 | 101 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 2006 | 34 | 0.020 |
Why?
|
| Topotecan | 1 | 2006 | 49 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 478 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 236 | 0.020 |
Why?
|
| Oocytes | 1 | 2008 | 272 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 731 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 988 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1625 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 1005 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5246 | 0.010 |
Why?
|
| Quality of Life | 1 | 2010 | 2092 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 12956 | 0.010 |
Why?
|